# A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

> clinical trial · VERIFIED · 2026-08-05

Status: ACTIVE_NOT_RECRUITING · Sponsor: AstraZeneca · Condition: Urinary Bladder Neoplasms

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03459846

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.